The metabolic fate of [1-14C] glucosamine, of N-acetyl[1-14C]glucosamine and of glycoproteins labelled with [1-14C]glucosamine was studied in rats for a period of 24hr. after these materials were given orally or injected. When [1-14C]glucosamine was injected 26.3% of the label was excreted in the urine, 19.7% was expired as carbon dioxide and 12.7% was incorporated into plasma proteins. When the same compound was given orally, 49-2% of the label was expired as carbon dioxide, with little appearing in the urine or in the plasma. When N-acetyl glucosamine was injected, 51.3% of the label was excreted in the urine with 12.3% appearing in carbon dioxide, but there was little incorporation into plasma protein. When this compound was given orally, 46.5% of the label was expired as carbon dioxide, 7.4% was recovered in the urine and 1.7 % was incorporated into plasma protein. After the injection of 14C-labelled glycoprotein 2 1.0% of the label was expired as carbon dioxide, whereas when it was given orally 49.8% of the label was recovered in carbon dioxide. The differences observed between the metabolic fate of the amino sugars when they were given orally and their fate when injected could not be accounted for by the action of the intestinal microflora or by the rate of administration of the material. It is concluded that amino sugars undergo metabolic alteration or degradation during absorption.
The amino sugar D-glucosamine is widely distributed in Nature, occurring principally as N-acetylglucosamine, a component of many mucopolysaccharides and glycoproteins. The intermediary metabolism of glucosamine in many organisms has been studied and interest has recently focused on the mechanisms ofbiosynthesis ofmacromolecules containing glucosamine (see Jeanloz & Balazs, 1966) . Little attention has been given to the assimilation and consequent metabolism of glucosamine when it is ingested by mammals, though the sugar occurs commonly in the diet. Capps, Shetlar & Bradford (1966) have shown that both glucosamine and N-acetylglucosamine can be absorbed by rats, but their studies gave little indication ofthe subsequent metabolic fate ofthe compounds. The fate of injected glucosamine has been investigated by Shetlar, Bradford, Hern, Endecott & Schilling (1962) , by Shetlar, Capps & Hern (1964) and by Kohn, Winzler & Hoffman (1962) , who also studied the fate of injected N-acetylglucosamine.
In the present work, the metabolic fate of orally administered [1-14C] glucosamine, N-acetyl[1-14C]-glucosamine and [1-14C]glucosamnine-labelled glycoproteins was studied after they had been fed to rats in order to establish the extent to which dietary glucosamine could be absorbed and utilized. For comparison the fate of amino sugar intravonously injected as these various forms was investigated. A preliminary communication of this work has been published (Robinson, 1967) .
MATERIALS AND METHODS
D-[1-14C]Glucosamine hydrochloride (specific activity 31 mc/m-mole) was obtained from The Radiochemical Centre (Amersham, Bucks.). N-Acetyl-D-[1-14C]glucosamine (specific activity 3-1 mc/m-mole) was prepared by the method described by Kuhn & Bister (1958) and the identity and purity ofthe product were confirmed by paper chromatography as described below. Plasma glycoprotein labelled in the N-acetylglucosamine and sialic acid (N-acetylneuraminic acid) moieties was obtained from rats by injecting [1-14C] glucosamine intraperitoneally in five consecutive 2,uc doses at hourly intervals. Blood was collected by cardiac puncture 2 hr. after the last injection and the plasma was separated by centrifugation. The plasma was dialysed against distilled water (two changes) to remove all radioactive material soluble in 5% (w/v) trichloroacetic acid.
The plasma protein was freeze-dried, dissolved in 0*15M-NaCl (30mg./ml.), centrifuged to remove denatured material and stored at -20°. Analysis of the glycoprotein by the methods described below showed that 67% of the label was present in N-acetylglucosamine and 33% in sialic acid. The specific activity of the glycoprotein was 6.6m,uc/mg.
Male Wistar rats (240-260g. body wt.) were used; food and water were given ad libitum during the experiments. The animals were caesarian-derived stock from Scientific Products Ltd. (Ash, Canterbury, Kent).
Gastric intubation was employed for the oral administration of the labelled compounds. [1-14C] Glucosamine and N-acetyl[1-14C]glucosamine were given dissolved in 0-15M-NaCl; 14C-labelled plasma glycoprotein was denatured by addition of 1 vol. of 10% (w/v.) trichloroacetic acid, and the precipitated protein was washed twice with 95% (v/v) ethanol and suspended in water (15mg./ml.).
Radioactive sugars and native plasma glycoprotein were injected in solution in 0 15m-NaCl into the femoral vein, under light ether anaesthesia.
After receiving the labelled compounds, animals were kept in metabolic cages to facilitate the collection of urine, faeces and CO2. C02-free air was circulated through the cages and expired CO2 was trapped in ethanolamine. Measurements of the efficiency of CO2 recovery were made by slowly releasing CO2 from known amounts of NaH'4C03 solution within the metabolic cages and subsequently measuring the radioactivity of the ethanolamine; 98-100% of the label was recovered. Immediately after termination of the collections the animals were anaesthetized with ether and blood was obtained by cardiac puncture. In some experiments the gastrointestinal tracts were removed from the animals and the contents of these organs were recovered by washing out with water. The contents, including the faeces, and the gastrointestinal-tract tissues were homogenized in water separately for the measurement of radioactivity.
The radioactivity ofsamples was measured by scintillation counting with internal standardization of samples. Whole plasma (0-4ml.) and plasma proteins were dissolved in Hyamine hydroxide (1 ml.) before the addition of scintillation liquid (6ml.). The radioactivity of homogenates of gastrointestinal-tract tissue and ofits contents was measured bythe oxidation method ofJeffay & Alvarez (1961) . Samples of ethanolamine-trapped 14CO2 and urine were added directly to scintillation liquid. Portions of paper chromatograms were counted immersed in scintillation fluid.
Sialic acid was released from biosynthetically 14C-labelled glycoprotein by hydrolysis in 5% (w/v) trichloroacetic acid (5 ml.) at 800 for 1 hr. after the protein had been previously precipitated in 5% trichloroacetic acid. The insoluble protein was removed from the hydrolysate by centrifugation and the supernatant was extracted with ether (5 x 1 vol.) to remove the trichloroacetic acid. The extracted solutions were applied to 1 cm. x 1Ocm. columns of Dowex 1 (C1-form; 200-400 mesh) resin, and the columns were washed with water to recover hexoses and hexosamines. The sialic acid was then eluted from the columns with 0-2 N-HCI (lOml.) and the eluates were dried in vacuo and redissolved in water for counting, paper chromatography and colorimetric determination (Warren, 1959) with N-acetylneuraminic acid as a standard. For chromatography, the solvent employed was butan-1-ol-propan-1-ol-N-HCl (1:2:1, by vol.). The residue from the trichloroacetic acid hydrolysis was further hydrolysed in 3N-HCl for 4hr. at 100°. These hydrolysates were combined with the above aqueous washings and were dried in vacuo, redissolved in water and the hexosamines were isolated on columns (1 cm. x 1Ocm.) of Dowex 50 (H+ form) resin (Boas, 1953) . The column eluates were dried in vacuo and redissolved for counting and colorimetric determinations (Boas, 1953) . The identity of the amino sugar was confirmed by paper chromatography in ethyl acetate-pyridine-water (10:4:3, by vol.) and butan-l-ol-acetic acid-water (4:1:5, by vol.) on Whatman no. 1 paper. The former solvent separated galactosamine and glucosamine sufficiently well to show that more than 90% of the radioactivity was associated with glucosamine, but glucosamine could not be separated from mannosamine.
In some experiments the presence of micro-organisms in the gastrointestinal tract was examined by suspending the total caecal contents from each animal in 50ml. of 0-15M-NaCl-0-05M-KH2PO4 buffer, adjusted to pH7-4 with 2N-KOH, containing glucose (0-5%). Samples (0-lml.) of suspension were cultured in brain-heart infusion broth, cooked-meat broth and on blood-agar and nutrient-agar (Oxoid Ltd., London, S.E. 1). The cultures were examined for growth after various times of incubation (maximum time 2 days) at 370 and 220 under aerobic and anaerobic conditions. (Table 3) .
RESULTS
Injected radioactivity entered the bloodstream immediately whereas that derived from the diet presumably entered considerably more slowly over a period of hours. As this difference could have affected the fate of the label, it was investigated by infusing rats under Nembutal anaesthesia with glucosamine (2.3,tmoles, luc in lml.) into the peritoneal cavity. Since earlier observations (Molnar, Robinson & Winzler, 1965) showed that glucosamine given by intraperitoneal injection was used as effectively as intravenously injected glucosamine for plasma glycoprotein synthesis, this mode of administration was adopted on account of its greater ease. The mean result from two experiments terminated after a 6hr. period of infusion was that 4.8% of the radioactivity of the dose appeared in carbon dioxide, 38.9% was in the urine and 32.0% was retained in the plasma. Thus major proportions of the label appeared in the urine and plasma, in agreement with the results for intravenous injection, and it was concluded that the period over which the 14C-labelled compounds were administered did not markedly influence their utilization.
The nature of the radioactive material present in the plasma of animals given the 14C-labelled compounds orally and by injection was investigated as described; in all cases the label was associated Vol. 108 protein-bound glucosamine, 10% was in proteinbound sialic acid and 20% was associated either with hexoses or with amino acids. The molecular size of the radioactive components appearing in the urine was investigated by gel filtration of urine samples on Sephadex G-25 gel.
When [1-14C]glucosamine was injected only 2% of the radioactive material in the urine was excluded on gel filtration, and when it was given orally 10% of the radioactive material was excluded by the gel, showing that in both instances the label is in material excreted predominantly in low-molecularweight form. In contrast, when 14C-labelled glycoprotein was either given orally or injected, some 50% of the radioactive material in the urine was excluded by the gel, In several experiments the metabolic fate of orallyadministered [1-14C]glucosamine was followed when the dose was increased (Table 4) . Increasing the dose from 2-3,umoles to 460,umoles had little effect on the metabolic fate, except that perhaps less of the label was expired as carbon dioxide.
DISCUSSION
The present finding, that within 24hr. after the injection of [1-14C]glucosamine into rats 19.7% of the label appeared in carbon dioxide with 26-3% in the urine and 12.7% in the plasma protein, is in general agreement with the results reported by Kohn et al. (1962) and by Shetlar et al. (1962 Shetlar et al. ( , 1964 . The finding that only 12.3% of the label from injected N-acetyl[1-14C]glucosamine appeared in carbon dioxide in 24hr. is markedly different from the value obtained by Kohn et al. (1962) . These authors showed that the expired radioactivity was decreased by giving glucose to the starved animals, and thus, in the present studies with fed animals, preferential utilization of glucose could account for the low value obtained. The longer time-interval employed in the present study would account for the finding that more radioactivity was excreted in the urine than was reported by Kohn et al. (1962) .
Within 4hr. of [1-14C] glucosamine injection some 25% of the injected radioactivity is incorporated into plasma protein as glucosamine and as sialic acid (Shetlar, Hem, Bradford & Endecott, 1961; Robinson, Molnar & Winzler, 1964) . In the present work only 12-7% of the injected radioactivity was found in plasma glycoprotein after 24hr., indicating a rapid catabolism ofplasma glycoprotein; the half-life of plasma protein-bound glucosamine in rats has been given as approx. 19 hr. (Macbeth, Bekesi, Sugden & Bice, 1965) . The finding that 66 % of the radioactivity of the injected 14C-labelled plasma glycoprotein was removed from the plasma in 24 hr. is also in accord with this conclusion. Kohn et al. (1962) and Richmond (1963) have reported that N-acetylglucosamine is only slowly incorporated into glycoprotein, a result confirmed here.
When [1-14C] glucosamine or N-acetyl[1-14C]-glucosamine was given orally to rats, 50% of the label was recovered in carbon dioxide, less than 3% was retained in the plasma and 3% ([1-14C]-glucosamine) or 7% (N-acetyl[1-14C] glucosamine) appeared in the urine. These results are markedly different from those obtained when these substances were injected. That there was a difference between the fates of orally administered and injected glucosamine was first indicated by Kawabe (1934) , who found that only 15% of an oral dose of glucosamine appeared in the urine of rabbits whereas 25-30% of an injected dose was excreted by this route, and the present experiments confirm such a difference. With [1-14C] Capps et al. (1966) gave glucosamine in doses of 1 m-mole orally to starved animals and found after 3hr. that 30% of the dose had been absorbed and that of this 18 % had been oxidized to carbon dioxide. They further reported that oral neomycin treatment decreased the extent to which the glucosamine was converted into carbon dioxide, in contrast with the results obtained in the present study. It is difficult to compare results from studies performed over markedly different time-periods with different doses of glucosamine, but Capps et al. (1966) found that the absorption coefficient of glucosamine was decreased in the neomycin-treated animals, and a slowed or delayed absorption in these animals might account for the decreased rate of oxidation observed over a short time-interval.
The differences in the results obtained on oral administration and injection may be explained by assuming that at least a proportion of the 14C_ labelled compounds given orally were either metabolized by the gastrointestinal tract to carbon dioxide or were altered by the gastrointestinal tract to substances other than glucosamine that were subsequently converted into carbon dioxide. If a proportion of the amino sugar were absorbed intact, it would account for the finding that when [1-14C]glucosamine is given orally some radioactive glucosamine is incorporated into plasma glycoprotein and some radioactivity is excreted in the urine. On the basis of this assumption, then by analogy with the results obtained on injection, where 12% of the label was found in the plasma after 24hr., the 3% found in the plasma after oral administration would represent an absorption of some 25% of the administered dose in the form of glucosamine. Similarly, if some N-acetyl[1-14C]-glucosamine were absorbed unaltered, by analogy with the results of injected animals, more radioactivity would be found in the urine than would be retained in the plasma, as was found to be the case.
In discussing these findings it is relevant to consider the dietary intake of glucosamine by the rat in relation to the rate at which glucosamine is utilized. In 24hr. the animals consumed 20-30g. Thus the glucosamine requirement for the plasma protein synthesis is 56-4,umoles/24hr., which cannot be supplied entirely from the diet. It is not possible, from the data available, to assess the total daily rate of glucosamine utilization in the rat, but, since all tissues contain glucosamine bound in macromolecules, the total amount of glucosamine used must be greater than that required for plasma protein biosynthesis. Consequently there must be an endogenous synthesis of glucosamine unless amino sugar, resulting from the degradation of macromolecules, is reutilized.
The fate of orally administered 14C-labelled glycoprotein is very similar to the fate of orally administered [1-14C] glucosamine. This suggests that the glycosidases present in the gastrointestinal tract are capable of degrading glycopeptide-bound carbohydrates. Though the glycoprotein contains labelled sialic acid it is unlikely that this is absorbed intact, since injected sialic acid is almost quantitatively excreted in the urine (Johnson, Kistler & McCluer, 1961) , and little radioactivity was recovered in the urine of animals given 14C-labelled glycoprotein orally.
In feeding experiments with [1-14C]glucosamine and with 14C-labelled glycoprotein, approx. 10% ofthe lab-l was recovered in the faeces and intestinal contents. It is not clear from these experiments if this radioactivity represents material that remains unabsorbed in the intestinal lumen or whether it is due to radioactive components that have been incorporated into glycoproteins in the intestinal tract and subsequently secreted back into the lumen.
